Navigation Links
Health fears over CO2 storage are unfounded, study shows
Date:9/12/2011

Capturing CO2 from power stations and storing it deep underground carries no significant threat to human health, despite recently voiced fears that it might, a study has shown.

Researchers found that the risk of death from poisoning as a result of exposure to CO2 leaks from underground rocks is about one in 100 million far less than the chances of winning the lottery jackpot.

Scientists from the University of Edinburgh studied historical data on deaths from CO2 poisoning in Italy and Sicily, where the gas seeps naturally from the ground because of volcanic activity.

They found that the number of recorded deaths was very low and say that engineered gas storage underground could be even safer, as it will be planned and monitored.

Recent CCS projects in northern Europe and Canada have been criticised by residents over health concerns arising from potential leakage.

Carbon capture and storage enables collection of CO2 before it can escape into the atmosphere. The technology involves the collection of CO2 at a power station or industrial site. The gas is liquefied and piped to the storage site, where it is injected deep below ground. The gas is stored in microscopic rock pores and eventually dissolves in underground water. Storage sites will have several barriers between the store and the surface.

Storing CO2 gas underground prevents it from contributing to global warming. Such technologies will play an important role over the next 50 years, as a bridge to the development of clean energy.

Jennifer Roberts from the University of Edinburgh's School of GeoSciences, who undertook the work, said: "These Italian CO2 seeps are natural, are often neither sign-posted nor fenced off, and yet there have been remarkably few accidents."

Professor Stuart Haszeldine of the University of Edinburgh's School of GeoSciences, who led the study, said: "Our findings show that storing CO2 underground is safe and should allay any concerns that the technology poses a significant threat to health."


'/>"/>

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-650-4401
University of Edinburgh
Source:Eurekalert

Related biology technology :

1. Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc
2. Tengion to Present at Rodman & Renshaw 13th Annual Healthcare Conference
3. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
4. Chimerix to Present at Stifel Nicolaus 2011 Healthcare Conference
5. Clinical Integration Enables Leading Health Systems to Deliver Higher Quality, Cost-Effective Care
6. Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference
7. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
8. Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference
9. enLiven Yogurt Sponsors "Back to School Grocery Giveaway" to Keep Parents and Kids Eating Healthy Foods this Fall
10. Auxilium Pharmaceuticals to Present at the Morgan Stanley 2011 Healthcare Conference
11. PAREXEL International to Present at Robert Baird Healthcare Conference and William Blair Emerging Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)...  Today, the Fisher Center for Alzheimer,s Research Foundation ... study that could lead to the development of effective ... This groundbreaking research was conducted by the Fisher Center ... Dr. Paul Greengard , in the quest to ... Center scientists have linked a mutation that protects elderly ...
(Date:1/23/2017)... 23, 2017   Enteris BioPharma, Inc. , announced ... Sanofi to leverage Enteris, proprietary and patented ... develop an oral formulation of one of Sanofi,s preclinical ... Chief Executive Officer and Executive Chairman of Enteris BioPharma, ... the tremendous value our Peptelligence platform program offers in ...
(Date:1/23/2017)... CARLOS, Calif. , Jan. 23, 2017 /PRNewswire/ ... developing innovative treatments for neurodegenerative diseases and other ... has joined the company as Chief Medical Officer. ... translational and clinical development activities at Alkahest and ... Dr. Jackson most recently served as Executive Director ...
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic Systems ... Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products in ... patients in Japan, the new Nipro - Transonic JV is a natural next step ...
Breaking Biology Technology:
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
Breaking Biology News(10 mins):